BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8431889)

  • 1. Ovarian cancer screening.
    van Nagell JR; DePriest PD; Gallion HH; Pavlik EJ
    Cancer; 1993 Feb; 71(4 Suppl):1523-8. PubMed ID: 8431889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
    Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening.
    van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
    Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.
    Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ
    Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of ovarian cancer screening. A decision analysis model.
    Schapira MM; Matchar DB; Young MJ
    Ann Intern Med; 1993 Jun; 118(11):838-43. PubMed ID: 8480957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to decrease false-positive cases of ovarian cancer screening by transvaginal sonography.
    Misawa T; Asai M; Higashide K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):217-20. PubMed ID: 9261750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and early detection of ovarian cancer: mission impossible?
    Bast RC; Brewer M; Zou C; Hernandez MA; Daley M; Ozols R; Lu K; Lu Z; Badgwell D; Mills GB; Skates S; Zhang Z; Chan D; Lokshin A; Yu Y
    Recent Results Cancer Res; 2007; 174():91-100. PubMed ID: 17302189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvaginal sonography as a screening method for the detection of early ovarian cancer.
    DePriest PD; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1997 Jun; 65(3):408-14. PubMed ID: 9190966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of multiple serum markers in patients with stage I ovarian cancer.
    Woolas RP; Xu FJ; Jacobs IJ; Yu YH; Daly L; Berchuck A; Soper JT; Clarke-Pearson DL; Oram DH; Bast RC
    J Natl Cancer Inst; 1993 Nov; 85(21):1748-51. PubMed ID: 8411259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
    Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
    J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on ovarian cancer screening.
    Munkarah A; Chatterjee M; Tainsky MA
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.
    Sato S; Yokoyama Y; Sakamoto T; Futagami M; Saito Y
    Cancer; 2000 Aug; 89(3):582-8. PubMed ID: 10931457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.
    Pavlik EJ; Saunders BA; Doran S; McHugh KW; Ueland FR; Desimone CP; Depriest PD; Ware RA; Kryscio RJ; van Nagell JR
    Cancer; 2009 Aug; 115(16):3689-98. PubMed ID: 19603478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of ovarian cancer.
    Badgwell D; Bast RC
    Dis Markers; 2007; 23(5-6):397-410. PubMed ID: 18057523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.